Status:
COMPLETED
Effects of Dynorphin 1-13 on Heroin Addiction - 1
Lead Sponsor:
University of Minnesota
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Opioid-Related Disorders
Substance Withdrawal Syndrome
Eligibility:
All Genders
18-55 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to evaluate the effects of IV dynorphin in humans during acute heroin abstinence, in order to determine that dynorphin suppresses acute opiate withdrawal, reduces opiate c...
Detailed Description
Randomized double blinded study of the effects of a single IV dose of dynorphin A 1-13 on heroin withdrawal in human opiate addicts
Eligibility Criteria
Inclusion Criteria:
opiate addict between the ages of 18-55
Exclusion Criteria:
Regular abuse of other drugs, unstable medical conditions
Key Trial Info
Start Date :
August 1 1994
Trial Type :
INTERVENTIONAL
End Date :
March 1 1997
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00000244
Start Date
August 1 1994
End Date
March 1 1997
Last Update
May 27 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
U of Minnesota School of Medicine
Minneapolis, Minnesota, United States, 55415